Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India.
Abstract
[BACKGROUND] Variants in the TUBB4A gene are associated with dystonia (DYT-TUBB4A), Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum (H-ABC) and spastic paraplegia. Phenotypes intermediate to these three broad phenotypes are also observed. These are rare disorders, and data from diverse populations remains limited. We report seven Indian cases with dystonia phenotype related to TUBB4A mutation.
[CASES] Among these seven patients, age at onset ranged from 5 to 48 years. Five patients had cranio-cervical onset of dystonia. One patient had prominent parkinsonism with dystonia. Patients responded well to botulinum toxin injected for laryngeal, cervical and jaw dystonia. The patient with parkinsonism responded well to levodopa, albeit with development of dyskinesias. Apart from the common p.Arg2Gly variant in three patients with DYT-TUBB4A, other variants included p.Arg262Pro, p.Arg39Cys and p.Asp245Asn.
[CONCLUSIONS] We report the first collection of cases with TUBB4A mutation from India. We expand the phenotype to include levodopa-responsive parkinsonism. Indian patients, consistent with global literature, harbor prominent adductor dysphonia, cervical and jaw dystonia, which responds well to botulinum treatment.
[CASES] Among these seven patients, age at onset ranged from 5 to 48 years. Five patients had cranio-cervical onset of dystonia. One patient had prominent parkinsonism with dystonia. Patients responded well to botulinum toxin injected for laryngeal, cervical and jaw dystonia. The patient with parkinsonism responded well to levodopa, albeit with development of dyskinesias. Apart from the common p.Arg2Gly variant in three patients with DYT-TUBB4A, other variants included p.Arg262Pro, p.Arg39Cys and p.Asp245Asn.
[CONCLUSIONS] We report the first collection of cases with TUBB4A mutation from India. We expand the phenotype to include levodopa-responsive parkinsonism. Indian patients, consistent with global literature, harbor prominent adductor dysphonia, cervical and jaw dystonia, which responds well to botulinum treatment.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | Basal Ganglia
|
scispacy | 1 | ||
| 해부 | cervical
|
scispacy | 1 | ||
| 해부 | jaw
|
scispacy | 1 | ||
| 합병증 | adductor dysphonia
|
scispacy | 1 | ||
| 약물 | levodopa
|
C0023570
levodopa
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Variants
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 약물 | botulinum
|
scispacy | 1 | ||
| 질환 | dystonia
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | Atrophy
|
C0333641
Atrophic
|
scispacy | 1 | |
| 질환 | spastic paraplegia
|
C0037772
Spastic Paraplegia
|
scispacy | 1 | |
| 질환 | parkinsonism
|
C0242422
Parkinsonian Disorders
|
scispacy | 1 | |
| 질환 | dyskinesias
|
C0013384
Dyskinetic syndrome
|
scispacy | 1 | |
| 질환 | levodopa-responsive parkinsonism
|
scispacy | 1 | ||
| 질환 | dysphonia
|
C1527344
Dysphonia
|
scispacy | 1 | |
| 질환 | H-ABC
→ Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum
|
scispacy | 1 | ||
| 질환 | cranio-cervical
|
scispacy | 1 | ||
| 질환 | laryngeal
|
scispacy | 1 | ||
| 질환 | jaw dystonia
|
scispacy | 1 | ||
| 질환 | Arg262Pro
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | TUBB4A
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | Arg2Gly
|
scispacy | 1 |
MeSH Terms
Humans; India; Male; Female; Adult; Phenotype; Middle Aged; Tubulin; Young Adult; Adolescent; Child; Dystonic Disorders; Child, Preschool; Genotype; Mutation; Dystonia
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.